<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05121675</url>
  </required_header>
  <id_info>
    <org_study_id>849894</org_study_id>
    <nct_id>NCT05121675</nct_id>
  </id_info>
  <brief_title>Investigating How Incentives Impact Engagement With an Online Mental Health Application (Neuroflow)</brief_title>
  <official_title>Investigating How Incentives Impact Engagement With an Online Mental Health Application (Neuroflow)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NeuroFlow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to understand how incentives (either points alone or points that&#xD;
      can be exchanged for gift certificates) encourage engagement with an online mental health app&#xD;
      (Neuroflow) for University students. Overall, the hope of this study is to help us understand&#xD;
      how best to support mental health and wellness in university students.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As mental health awareness and intervention has gained more traction throughout the years,&#xD;
      applications - such as NeuroFlow - have emerged in an effort to facilitate aid to those who&#xD;
      are unable to afford or access alternative mental health care methods (Huckvale et al, 2020).&#xD;
      However, over 95% of mental health and wellness applications have not actually been studied&#xD;
      (Lecomte et al., 2020). Additionally, a large portion examines user adoption of various&#xD;
      mental health applications based on different factors, leaving a gap in research regarding&#xD;
      client engagement and interest post-installation (Huang and Bashir, 2017). Thus, despite&#xD;
      promises, applications for promoting mental health often do not achieve their intended goals&#xD;
      due to lack of sufficient client engagement/interest. In order to address this discrepancy,&#xD;
      the use of financial incentives and other incentives from the field of behavioral economics&#xD;
      may help (Beidas et al., 2019). As an application, NeuroFlow embeds behavioral economic&#xD;
      principles to increase motivation and engagement with the application (such as personalized&#xD;
      pop-up notification reminders and app gamification including points accrual for activity&#xD;
      completion and celebratory messages for meeting points thresholds) and also provides&#xD;
      financial incentives whereby points accrued can be redeemed into gift cards for popular&#xD;
      outlets such as Amazon. However, it is not clear if this financial incentive increases&#xD;
      engagement or has knock-on effects for mental health and wellbeing over and above the&#xD;
      behavioral economics incentives per se. In this study, we will conduct a pilot two-arm&#xD;
      randomized controlled trial where we will examine the effect of a treatment group (NeuroFlow&#xD;
      app with behavioral economics and financial incentives vs. NeuroFlow app with behavioral&#xD;
      economics incentives only) on application engagement and mental health and wellbeing (anxiety&#xD;
      and depression symptoms, sleep, self-regulation and wellbeing). The purpose of this study is&#xD;
      to gain an understanding of how incentives encourage participation and engagement with an&#xD;
      online mental health platform, NeuroFlow.&#xD;
&#xD;
      This study is a two-arm pilot randomized controlled trial to assess differences in user&#xD;
      retention and usage rates associated with two incentive structures within the NeuroFlow app&#xD;
      (I.e., general structure versus financial compensation). We will assess user engagement with&#xD;
      utilization data (ie., daily, weekly, and monthly active users) and measures of the total&#xD;
      number of activity counts completed by a user. After consenting to participate in the study,&#xD;
      participants will be randomly assigned to use Neuroflow either with points only or with&#xD;
      points and the opportunity to exchange those points for gift cards. In both conditions,&#xD;
      participants will begin by completing a consent form and a brief questionnaire with their&#xD;
      contact information, which will be used to grant them access to the Neuroflow platform.&#xD;
&#xD;
      In both recruitment methods, participants will be required to sign up for a 15 minute check&#xD;
      in and check out meeting before and after the trial to answer participant questions regarding&#xD;
      the app/app set up or concerns about the consent form. Furthermore, a Qualtrics survey will&#xD;
      also be dispersed to participants to be taken during this time along with an initial baseline&#xD;
      assessment (to be administered in the NeuroFlow app).&#xD;
&#xD;
      Baseline and post-app usage Qualtrics survey links will also be sent with measures&#xD;
      (Generalized anxiety disorder (GAD), Patient Health Questionnaire (PHQ), World Health&#xD;
      Organization- Five Well-Being Index (WHO-5), and Difficulties in Emotion Regulation Scale&#xD;
      (DERS)) to participants in order to assess differences in user retention.&#xD;
&#xD;
      In both conditions, participants will use the Neuroflow app throughout the duration of the&#xD;
      4-week study (28 days). Participants will be sent a push notification each day through the&#xD;
      app to complete their daily activities, which could include surveys, videos, or skill-based&#xD;
      practice materials.&#xD;
&#xD;
      With the collaboration of the Neuroflow team, the usage metrics of the app will be pulled&#xD;
      after the end of the study. The user metrics of interest are identifying factors that include&#xD;
      first name, last name, gender, age, date of birth, and the applicable assignments to each&#xD;
      participant - care team manager and behavioral health specialist. Additionally, the first and&#xD;
      last score, first and last date, and time between the first and last assessment dates for the&#xD;
      measures of interest (PHQ-9, GAD-7, WHO-5, DERS). Furthermore, the total activity number and&#xD;
      the total activity rate across all measures will be collected. No additional data from or&#xD;
      about participant phone usage or activities will be pulled as part of the study other than&#xD;
      the usage metrics specified above, specific to Neuroflow.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to one of the two arms. The participants getting the app with behavioral economics incentives only will be enrolled at the same time as the participants getting the app with behavioral economics + financial incentives.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will be randomized to one of the two groups and will not be informed of which one. If they directly ask we will tell them at the end of the trial.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Engagement</measure>
    <time_frame>28 days (specific end date of study varies depending on participant start date)</time_frame>
    <description>User engagement will be measured as the percentage of daily check-in activities (number completed out of the total number of activities assigned)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety symptoms</measure>
    <time_frame>28 days (specific end date of study varies depending on participant start date)</time_frame>
    <description>Change from pre-trial to post-trial score in anxiety (measured with the GAD)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptoms</measure>
    <time_frame>28 days (specific end date of study varies depending on participant start date)</time_frame>
    <description>Change from pre-trial to post-trial score in depression (measured with the PHQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental Wellbeing measurement</measure>
    <time_frame>28 days (specific end date of study varies depending on participant start date)</time_frame>
    <description>Change from pre-trial to post-trial score in mental wellbeing (measured with the WHO)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotion regulation ability</measure>
    <time_frame>28 days (specific end date of study varies depending on participant start date)</time_frame>
    <description>Change from pre-trial to post-trial score in emotion regulation (measured with the DERS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>App With Behavioral Economics Incentives Only</condition>
  <condition>App With Behavioral Economics + Financial Incentives</condition>
  <arm_group>
    <arm_group_label>App with behavioral economics + financial incentives</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeuroFlow uses behavioral economics reminders, gamification, and fun, motivating messages to encourage use. It also includes financial incentives so users can earn redeemable points accrued for activity completion for gift cards at popular outlets (e.g., 1000 points which is the maximum per month = $10 gift card).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>App with behavioral economics incentives only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NeuroFlow uses behavioral economics reminders, gamification, and fun, motivating messages to encourage use. including points accrued for activity completion. This version of the app does not have financial incentives.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuroflow app: Mental health and wellbeing resources for adults</intervention_name>
    <description>The NeuroFlow app delivers resources on resilience training, mindfulness-based strategies and cognitive behavioral therapy to adults looking to support their mental health and wellbeing. The specific &quot;journey&quot; (i.e., content such as activities, videos, trackers, and journaling) is tailored to individuals based on depression and anxiety screeners administered upon signing up to the app.</description>
    <arm_group_label>App with behavioral economics + financial incentives</arm_group_label>
    <arm_group_label>App with behavioral economics incentives only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The target population for this study are college students either at the University of&#xD;
             Pennsylvania or other US universities. Participants will be included if they have a&#xD;
             smartphone and are willing to download and use the Neuroflow app throughout the&#xD;
             duration of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Does not own a smartphone capable of downloading the NeuroFlow application or is&#xD;
             unwilling to download and use the Neuroflow app throughout the duration of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Nuske</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cheryl Chang</last_name>
    <phone>5169968699</phone>
    <email>cherylcc@sas.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heather Nuske</last_name>
    <email>heather.nuske@pennmedicine.upenn.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Huang HY, Bashir M. Users' Adoption of Mental Health Apps: Examining the Impact of Information Cues. JMIR Mhealth Uhealth. 2017 Jun 28;5(6):e83. doi: 10.2196/mhealth.6827.</citation>
    <PMID>28659256</PMID>
  </reference>
  <reference>
    <citation>Huckvale K, Nicholas J, Torous J, Larsen ME. Smartphone apps for the treatment of mental health conditions: status and considerations. Curr Opin Psychol. 2020 Dec;36:65-70. doi: 10.1016/j.copsyc.2020.04.008. Epub 2020 May 4. Review.</citation>
    <PMID>32553848</PMID>
  </reference>
  <reference>
    <citation>Lecomte T, Potvin S, Corbi√®re M, Guay S, Samson C, Cloutier B, Francoeur A, Pennou A, Khazaal Y. Mobile Apps for Mental Health Issues: Meta-Review of Meta-Analyses. JMIR Mhealth Uhealth. 2020 May 29;8(5):e17458. doi: 10.2196/17458.</citation>
    <PMID>32348289</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 2, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

